Learn more in our training program.
Join our membership network.
Attend our events and collaborate.
Add your voice to our policy matters.
Get involved in our genetic registry.
Donate to our cause.
The Latino Cancer Institute (TLCI) is a nationwide community and research network dedicated to solving the issues and burden of Latino cancer.
Heart disease has surpassed cancer as the leading cause of death among Hispanics/Latinos in the U.S. However, cancer remains a major health concern, accounting for approximately 17% of deaths. Through public education, community resources, and improved access to care, survival rates continue to improve.
Breast cancer remains the most commonly diagnosed cancer and the leading cause of cancer death among Hispanic/Latina women. Additionally, cervical cancer rates continue to pose a serious threat to Latinas. In the fall 2024, The Latino Cancer Institute hosted a Virtual Friday Forum Series, bringing together leading voices in the field to discuss the latest research findings and promising interventions.
Lung cancer continues to be the leading cause of cancer death among Hispanic/Latino men. While smoking rates are lower among Latinos compared to other groups, targeted prevention efforts and early detection remain critical.
The Latino Cancer Institute is committed to reducing the burden of cancer in Latino communities through advocacy, research, and community-driven solutions. Learn more about us.
05 Mar, 2025 | Forum, Genetics, Health, News and Information
For over 20 years, Founder Ysabel Duron has played a vital role in bringing together those dedicated to making a difference in the Latino cancer landscape. From cancer community workers and caregivers to international medical researchers and policymakers, Ysabel has forged important alliances in a field crowded with many competing interests and agendas.
It takes a savvy insider who has traveled this terrain far and wide to help the Latino cancer community at-large continue changing the landscape. TLCI offers the definitive road map.
The Latino Cancer Institute acts as a network for agencies, linking members to share knowledge and best practices. Connecting colleagues, peers and institutions is critical to The Institute’s ongoing mission to amplify and disseminate outstanding work in the cancer arena, and to support one another.
The Latino Cancer Institute provides opportunities to network, learn and collaborate with stakeholders in the cancer landscape including Latino cancer researchers.
The Latino Cancer Institute leverages our united voice at the national table to advance Latino cancer concerns including education, services, funding, and research. Our aim is to be heard, understood and included in any proposed policy.
As a nonprofit organization, we rely on philanthropy and grants in our mission to support other agencies. Your funding allows us to continue the development of new programs and tools we can share with those making a difference in the lives of Latino cancer patients, survivors, and their caregivers.
A team has found two antibodies that can work together to neutralize the virus that causes COVID-19 in all its current known variations in a laboratory environment. More research is needed, but the approach shows promise in developing treatments to keep pace with evolving viruses.
Scientists have uncovered the mechanism behind how aspirin could reduce the metastasis of some cancers by stimulating the immune system. The scientists say that discovering the mechanism will support ongoing clinical trials, and could lead to the targeted use of aspirin to prevent the spread of susceptible types of cancer, and to the development of more effective drugs to prevent cancer metastasis.
Researchers used a double-pronged approach to reduce tumor growth in tissue samples of prostate cancer.
Scientists have uncovered new genetic clues that explain why some prostate cancers remain slow-growing while others become life-threatening.
Researchers have developed an innovative tool that enhances surgeons' ability to detect and remove cancer cells during cryosurgery, a procedure that uses extreme cold to destroy tumors. This breakthrough technology involves a specialized nanoscale material that illuminates cancer cells under freezing conditions, making them easier to distinguish from healthy tissue and improving surgical precision.
DNA repair proteins act like the body's editors, constantly finding and reversing damage to our genetic code. Researchers have long struggled to understand how cancer cells hijack one of these proteins -- called polymerase theta (Pol-theta) -- for their own survival. But scientists have now captured the first detailed images of Pol-theta in action, revealing the molecular processes responsible for a range of cancers.
